Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a -21.547% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) COc1cc2[nH]c(=S)nc(NCc3ccc(C)cc3)c2cc1OC
b.) CC(C)CN1CCCC(N2CCN(c3cccc(Cl)c3)CC2)C1
Answer: b. CC(C)CN1CCCC(N2CCN(c3cccc(Cl)c3)CC2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)CN1CCCC(N2CCN(c3cccc(Cl)c3)CC2)C1
CC(C)CN1CCCC(N2CCN(c3cccc(Cl)c3)CC2)C1
1-(3-chlorophenyl)-4-[1-(2-methylpropyl)piperidin-3-yl]piperazine